Shiga Microalbuminuria Reduction Trial-2

Summary

The purpose of this study is to compare the effects of a direct renin inhibitor (DRI), aliskiren, on the urinary albumin excretion in hypertensive patients with type 2 diabetes under strict blood pressure control with angiotensin receptor blocker (ARB).

Timeline

Start

2011-10

Primary completion

2014-08

Completion

2014-12

Drugs

Indications